REQUEST A DEMO
Total
USD $0.00
Search more companies

Diagnostimax Medical S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Diagnostimax Medical S.A.S. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Diagnostimax Medical S.A.S. is an enterprise in Colombia, with the main office in Bucaramanga. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on January 20, 2017. 11 (2024) employees currently work for Diagnostimax Medical S.A.S.. There was a net sales revenue increase of 11.98% reported in Diagnostimax Medical S.A.S.’s latest financial highlights for 2023. A growth of 2.1% was recorded in its total assets. The net profit margin of Diagnostimax Medical S.A.S. increased by 0.01% in 2023.

Headquarters
Calle 15 # 16 - 57
Bucaramanga; Santander;

Contact Details: Purchase the Diagnostimax Medical S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Diagnostimax Medical S.A.S. report to view the information.
Outstanding Shares:
Purchase the Diagnostimax Medical S.A.S. report to view the information.
Incorporation Date:
January 20, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Diagnostimax Medical S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.98%
Total operating revenue
11.98%
Net Profit (Loss) for the Period
12.36%
Total assets
2.1%
Total equity
25.47%
Net Profit Margin
0.01%
Return on Equity (ROE)
-2.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?